Celsion (CLSN) jumps 12.9% after signing a technology development agreement for its ThermoDox...

|About: Celsion Corporation (CLSN)|By:, SA News Editor

Celsion (CLSN) jumps 12.9% after signing a technology development agreement for its ThermoDox liver-cancer treatment with China's Hisun, which will pay $5M upfront and manufacture the drug. The deal is a precursor to a China licensing agreement that could be worth hundreds of millions of dollars to Celsion, and comes ahead of the results of Phase III trials for ThermoDox. (PR)